compound 29 [PMID: 36356320]   Click here for help

GtoPdb Ligand ID: 12313

Compound class: Synthetic organic
Comment: This compound is a receptor tyrosine kinase inhibitor with selectivity for fibroblast growth factor receptors 2 and 3 (FGFR2/3) [2]. It is active at both the wild type kinases and at those with activiating mutations in the gatekeeper region (e.g. FGFR2V564I/L/M/F, FGFR3V555I/L/M/F) that are associated with malignancies such as cholangiocarcinoma and bladder cancer. Erdafitinib, pemigatinib and infigratinib are drugs that are already used clinically to target abberant FGFR signalling in specific solid tumour types. These are all pan-FGFR inhibitors and can cause hyperphosphatemia, most likely via activation of FGFR1 [1,3], so sparing this receptor is hypothesised to improve the toxicity profile of FGFR inhibiting drugs.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 108.46
Molecular weight 447.2
XLogP 2.5
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(c1cncc(c1)c1cnn2c1nc(O[C@@H]1COCC1)c(c2)c1cnn(c1)C(C)C)NC([2H])([2H])[2H]
Isomeric SMILES O=C(NC([2H])([2H])[2H])c1cc(c2c3nc(O[C@@H]4COCC4)c(c4cn(C(C)C)nc4)cn3nc2)cnc1
InChI InChI=1S/C23H25N7O3/c1-14(2)29-11-17(9-26-29)20-12-30-21(28-23(20)33-18-4-5-32-13-18)19(10-27-30)15-6-16(8-25-7-15)22(31)24-3/h6-12,14,18H,4-5,13H2,1-3H3,(H,24,31)/t18-/m0/s1/i3D3
InChI Key XKKGIGFZDVPVNO-NGGDXUQASA-N
Download 2D Structure Click here for help
Canonical SMILES Download
Isomeric SMILES Download
InChI standard identifier Download
InChI standard key Download

Molecular structure representations generated using Open Babel